Stockscreener 앱 받기
3.65
0.54%
-0.02
전일 마감가:
$3.67
열려 있는:
$3.65
하루 거래량:
424.93K
Relative Volume:
0.51
시가총액:
$481.65M
수익:
$193.01M
순이익/손실:
$-12.15M
주가수익비율:
-40.56
EPS:
-0.09
순현금흐름:
$454.00K
1주 성능:
+3.69%
1개월 성능:
-16.28%
6개월 성능:
-28.99%
1년 성능:
-38.34%
1일 변동 폭
$3.4746
$3.68
1주일 범위
$3.4746
$3.795
52주 변동 폭
$3.27
$7.63
Cytek Biosciences Inc Stock (CTKB) Company Profile
명칭
Cytek Biosciences Inc
전화
(877) 922-9835
주소
47215 LAKEVIEW BOULEVARD, FREMONT
CTKB을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CTKB
Cytek Biosciences Inc
|
3.65 | 481.65M | 193.01M | -12.15M | 454.00K | -0.09 |
|
ABT
Abbott Laboratories
|
130.98 | 221.92B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
95.12 | 139.43B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
346.50 | 134.90B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
82.60 | 108.02B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
71.53 | 40.93B | 5.72B | 4.17B | 259.90M | 6.97 |
Cytek Biosciences Inc Stock (CTKB) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-01-31 | 다운그레이드 | Goldman | Buy → Sell |
| 2023-12-14 | 개시 | Stephens | Overweight |
| 2023-07-19 | 개시 | Raymond James | Mkt Perform |
| 2022-01-06 | 재개 | Piper Sandler | Overweight |
Cytek Biosciences Inc 주식(CTKB)의 최신 뉴스
JPMorgan Chase & Co. Raises Stake in Cytek Biosciences, Inc. (NASDAQ:CTKB) - Defense World
Is Cytek Biosciences (NASDAQ:CTKB) Using Too Much Debt? - simplywall.st
Cytek Biosciences, Inc. (NASDAQ:CTKB) Shares Sold by Vanguard Group Inc. - Defense World
Corebridge Financial Inc. Decreases Position in Cytek Biosciences, Inc. (NASDAQ:CTKB) - Defense World
Cytek Biosciences, Inc. (NASDAQ:CTKB) Shares Bought by American Century Companies Inc. - Defense World
KLP Kapitalforvaltning AS Takes $131,000 Position in Cytek Biosciences, Inc. (NASDAQ:CTKB) - Defense World
Cytek Biosciences stock hits 52-week low at $3.51 amid market challenges - Investing.com
Trading (CTKB) With Integrated Risk Controls - news.stocktradersdaily.com
Prudential Financial Inc. Has $1.13 Million Stock Holdings in Cytek Biosciences, Inc. (NASDAQ:CTKB) - Defense World
Raymond James Financial Inc. Buys New Stake in Cytek Biosciences, Inc. (NASDAQ:CTKB) - Defense World
Thrivent Financial for Lutherans Sells 3,001 Shares of Cytek Biosciences, Inc. (NASDAQ:CTKB) - Defense World
Cell Analyzer | Cytek Biosciences Inc. | Products - Photonics Spectra
106,597 Shares in Cytek Biosciences, Inc. (NASDAQ:CTKB) Purchased by Teacher Retirement System of Texas - Defense World
Proficio Capital Partners LLC Invests $71,000 in Cytek Biosciences, Inc. (NASDAQ:CTKB) - Defense World
Cytek Biosciences stock hits 52-week low at $3.99 amid market shifts - Investing.com India
Cytek Biosciences, Inc. (NASDAQ:CTKB) Shares Purchased by PNC Financial Services Group Inc. - Defense World
Cytek Biosciences expands cell analysis offerings with the affordable, user-friendly Cytek Muse Micro System - SelectScience
Charles Schwab Investment Management Inc. Increases Stock Position in Cytek Biosciences, Inc. (NASDAQ:CTKB) - Defense World
Cytek Biosciences (NASDAQ:CTKB) Trading Up 2.2% – What’s Next? - Defense World
Stephens Reiterates “Overweight” Rating for Cytek Biosciences (NASDAQ:CTKB) - Defense World
Cytek Biosciences stock hits 52-week low at $4.05 - Investing.com India
Cytek Biosciences stock hits 52-week low at $4.05 By Investing.com - Investing.com UK
Cytek Biosciences Launches Next-Generation Muse Micro Cell Analyzer to Transform Flow Cytometry Accessibility - Nasdaq
Cytek® Biosciences Expands Cell Analysis Offerings with the Affordable, User-Friendly Cytek® Muse® Micro System - GlobeNewswire
Revolutionary Budget-Friendly Cell Analyzer Transforms Biotech Research Accessibility - StockTitan
Bank of New York Mellon Corp Grows Position in Cytek Biosciences, Inc. (NASDAQ:CTKB) - Defense World
Proficio Capital Partners LLC Takes Position in Cytek Biosciences, Inc. (NASDAQ:CTKB) - Defense World
Cytek Biosciences stock hits 52-week low at $4.19 amid market challenges - Investing.com Australia
Cytek Biosciences stock hits 52-week low at $4.19 amid market challenges By Investing.com - Investing.com South Africa
Cytek Biosciences (CTKB) to Release Earnings on Wednesday - The AM Reporter
Cytek Biosciences, Inc. (CTKB): Why Are Hedge Funds Bullish On This Cash-Rich Penny Stock? - Insider Monkey
12 Cash-Rich Penny Stocks To Buy According To Hedge Funds - Insider Monkey
Cytek Biosciences, Inc. (NASDAQ:CTKB) Q4 2024 Earnings Call Transcript - MSN
Cytek Biosciences (CTKB) Expected to Announce Quarterly Earnings on Wednesday - Defense World
Cytek Biosciences, Inc. (NASDAQ:CTKB) Shares Bought by Principal Financial Group Inc. - Defense World
Cytek Biosciences (NASDAQ:CTKB) Price Target Cut to $8.00 by Analysts at Piper Sandler - Defense World
Cytek Biosciences Reports Mixed Earnings Amid Growth and Challenges - TipRanks
Cytek Biosciences (NASDAQ:CTKB) Hits New 1-Year Low – Here’s Why - Defense World
Cytek Biosciences stock hits 52-week low at $4.6 amid market challenges - Investing.com Australia
Is There An Opportunity With Cytek Biosciences, Inc.'s (NASDAQ:CTKB) 22% Undervaluation? - Yahoo Finance
Cytek Biosciences (NASDAQ:CTKB) Releases Quarterly Earnings Results, Beats Estimates By $0.02 EPS - MarketBeat
Cytek Biosciences stock hits 52-week low at $4.6 amid market challenges By Investing.com - Investing.com South Africa
Cytek Biosciences, Inc. SEC 10-K Report - TradingView
Cytek Biosciences Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Cytek Biosciences Reports Growth and Strategic Expansion - TipRanks
Cytek Biosciences earnings beat by $0.01, revenue fell short of estimates - Investing.com Canada
Cytek Biosciences Inc (CTKB) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.01%
0.46%
자본화:
|
볼륨(24시간):